Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial

OBJECTIVE: We investigated the association between obesity and biomarkers indicating cardiac or renal dysfunction or inflammation and their interaction with obesity and outcomes. METHODS: A total of 14 753 patients in the Apixaban for Reduction In STroke and Other ThromboemboLic Events in Atrial Fib...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Open Heart
Autori principali: Sandhu, Roopinder K, Ezekowitz, Justin A, Hijazi, Ziad, Westerbergh, Johan, Aulin, Julia, Alexander, John H, Granger, Christopher B, Halvorsen, Sigrun, Hanna, Michael S, Lopes, Renato D, Siegbahn, Agneta, Wallentin, Lars
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2018
Soggetti:
Arrhythmias and Sudden Death
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6242013/
https://ncbi.nlm.nih.gov/pubmed/30487982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2018-000908
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi